ACI ORS Fruity

ACI ORS Fruity is indicated for the prevention and treatment of dehydration caused by fluid and electrolyte loss, most commonly due to acute diarrhoea (including cholera-associated diarrhoea, as an adjunct to appropriate antibiotic therapy when indicated), vomiting, or excessive sweating (e.g., heat exhaustion, strenuous exercise, febrile illness).

• Established/guideline-supported use: First-line oral rehydration therapy for mild-to-moderate dehydration from acute watery diarrhoea in infants, children, and adults, per WHO/UNICEF recommendations.
• Established/guideline-supported use: Prevention of dehydration in patients with ongoing diarrhoea or vomiting who are not yet dehydrated.
• Adjunct use: Supportive fluid and electrolyte replacement in cholera, used together with appropriate antimicrobial therapy and, in severe cases, alongside intravenous fluids.
• Adjunct/supportive use: Fluid replacement for mild fluid loss from excessive sweating, mild heat-related illness, or febrile illness, under medical advice.

ACI ORS Fruity is not indicated as a substitute for intravenous fluid therapy in patients with severe dehydration or shock.

Oral Rehydration Salt [Flavored] is an oral electrolyte-glucose rehydration formulation, typically supplied as a powder for reconstitution with clean drinking water, based on the WHO/UNICEF reduced-osmolarity oral rehydration salts formula, with added approved flavouring for palatability. A standard formula (per litre of prepared solution) contains:

This yields an approximate osmolarity of 245 mOsm/L with sodium ~75 mmol/L, potassium ~20 mmol/L, chloride ~65 mmol/L, citrate ~10 mmol/L, and glucose ~75 mmol/L, along with an approved food-grade flavouring agent (e.g., orange or lemon) to improve taste and encourage adequate intake, particularly in children. Exact excipient and flavour composition may vary slightly by manufacturer; refer to the product label for the specific formulation.

ACI ORS Fruity is a flavoured oral rehydration therapy formulated to replace water and electrolytes lost during diarrhoea, vomiting, or excessive sweating. It is based on the World Health Organization's reduced-osmolarity oral rehydration salts (ORS) formula, which combines glucose and electrolytes (sodium, potassium, chloride, citrate) in proportions that promote efficient water and sodium absorption in the small intestine.

Unlike plain ORS, the flavoured formulation contains an approved flavouring agent to improve palatability, which can help increase acceptance and intake, especially in children. ACI ORS Fruity is supplied as a powder in sachets that must be dissolved in a specific volume of clean, safe drinking water before use; it is not intended to be taken as a dry powder or in any other diluted or concentrated form.

ACI ORS Fruity belongs to the class of oral rehydration therapy (ORT) agents / electrolyte and carbohydrate replacement solutions. It is a nutritional/electrolyte-replacement preparation rather than a conventional pharmacologic drug, and is used for rehydration and maintenance of fluid-electrolyte balance.

Mechanism

Oral Rehydration Salt [Flavored] works through the glucose-sodium co-transport mechanism (SGLT1) present in the brush border of small intestinal enterocytes. Glucose actively co-transports sodium across the intestinal epithelium, and water follows passively along the resulting osmotic gradient. This mechanism remains functional even during secretory diarrhoea (e.g., cholera), which is why oral rehydration remains effective despite ongoing intestinal fluid losses.

The added potassium replaces losses from stool, and citrate (a bicarbonate precursor) helps correct the metabolic acidosis commonly associated with dehydration from diarrhoea. The reduced-osmolarity formulation used in Oral Rehydration Salt [Flavored] has been shown to reduce stool output, vomiting, and the need for supplemental intravenous fluids compared with older, higher-osmolarity formulas.

Pharmacokinetics

As an oral electrolyte-glucose solution, Oral Rehydration Salt [Flavored] is absorbed directly across the intestinal mucosa rather than undergoing systemic pharmacokinetic processing (absorption, distribution, metabolism, excretion) typical of pharmacologic agents. Absorbed electrolytes and fluid are handled by normal renal and homeostatic mechanisms.

ACI ORS Fruity is for oral use only. Dissolve the entire contents of one sachet in the exact volume of clean, safe drinking water specified on the label (do not estimate); stir until fully dissolved. Use a clean cup and spoon, or a feeding cup/spoon for infants; a bottle may be used if that is how the infant normally feeds. Prepare a fresh batch daily and discard any solution not used within 24 hours (store the prepared solution in a cool place, ideally refrigerated, and covered).

ACI ORS Fruity has a low potential for clinically significant drug interactions, as it is an electrolyte-glucose replacement solution rather than a systemically active drug. Documented considerations include:

• Potassium-sparing diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs): Concomitant use with ACI ORS Fruity may theoretically increase the risk of hyperkalemia because of the added potassium load; use with caution and monitor electrolytes if these are used together, particularly in patients with renal impairment.
• Other oral medications: No specific, well-established clinically significant interaction has been established with routine oral drugs; however, as a general precaution, other oral medicines can be taken as usual unless a physician advises otherwise.

When prepared and used correctly, ACI ORS Fruity is generally very well tolerated. Reported adverse effects are uncommon and usually related to incorrect preparation or excessive/rapid intake:

• Vomiting, if the solution is given too quickly or in large volumes at once.
• Abdominal bloating, distension, or mild discomfort.
• Hypernatremia or hyperkalemia, primarily if the solution is prepared too concentrated (insufficient water) or given to patients with impaired renal function (see Contraindications).
• Rarely, metabolic alkalosis with excessive intake.

ACI ORS Fruity is generally considered appropriate for use during pregnancy and breastfeeding when used as directed for rehydration, as it consists of water, electrolytes, and glucose rather than a systemically absorbed pharmacologic agent. However, as with any product used during pregnancy or lactation, it should be used only if clearly needed, and a physician should be consulted, particularly if dehydration is due to an underlying condition (e.g., hyperemesis gravidarum) that requires separate evaluation and management. Breastfeeding should be continued alongside ACI ORS Fruity therapy in lactating mothers and their infants.

ACI ORS Fruity must always be reconstituted with the exact volume of clean, safe drinking water specified on the label; do not add sugar, milk, fruit juice, or other substances, and do not use a more concentrated or more dilute solution than directed, as this can cause serious electrolyte imbalance (see Side Effects).

• Use with caution in patients with renal impairment, congestive heart failure, or conditions predisposing to impaired potassium excretion, due to the risk of fluid and electrolyte overload; medical supervision is advised in these situations (see Contraindications for severe cases).
• Use with caution in patients with diabetes mellitus, as the solution contains glucose; monitor blood glucose as advised by a physician.
• Seek immediate medical attention if there are signs of severe dehydration, bloody diarrhoea, high fever, persistent vomiting preventing oral intake, or if diarrhoea does not improve within 48 hours.
• Discard any prepared solution not used within 24 hours to avoid bacterial contamination.

Excessive or improperly prepared (over-concentrated) intake of ACI ORS Fruity may lead to hypernatremia, hyperkalemia, or fluid overload, particularly in young children, the elderly, or patients with renal or cardiac impairment. Symptoms may include irritability, lethargy, muscle weakness, swelling, or seizures in severe cases. If overdose or incorrect preparation is suspected, or if concerning symptoms develop, stop use and seek immediate medical attention or contact a poison control centre/emergency services; do not attempt to treat suspected electrolyte overdose at home.

Store dry sachets at room temperature (below 30°C), in a dry place away from light and moisture, and keep out of reach of children. Once reconstituted, keep the prepared solution covered in a cool place (refrigerate if possible) and discard any unused portion after 24 hours.

Infants and young children: ACI ORS Fruity is commonly used in infants and young children with diarrhoea, following age-appropriate volumes (see Dosage and Administration); breastfeeding or normal feeding should continue. Malnourished children may require closer monitoring during rehydration and should be managed under medical guidance.

Elderly: No dose adjustment is generally required based on age alone, but elderly patients, particularly those with renal impairment or heart failure, should be monitored for fluid overload or electrolyte disturbance.

Renal impairment: Use with caution; contraindicated in anuria/severe oliguria (see Contraindications). Electrolyte monitoring is advised in patients with lesser degrees of renal impairment.

Hepatic impairment: No specific dose adjustment is established; use as directed with routine clinical monitoring.

ACI ORS Fruity should be continued for as long as diarrhoea, vomiting, or significant fluid losses persist, and typically for 24-48 hours after symptoms resolve to help restore normal hydration status. Most episodes of acute diarrhoea improve within a few days. Medical advice should be sought if diarrhoea persists beyond 48-72 hours, worsens, or is accompanied by bloody stools, high fever, or signs of severe dehydration.

ACI ORS Fruity is supplied as a powder that must be reconstituted before use. Empty the entire contents of one sachet into a clean container and dissolve in the exact volume of clean, boiled-and-cooled (or otherwise safe) drinking water stated on the product label (commonly 200 mL, 500 mL, or 1 litre, depending on sachet size); stir thoroughly until completely dissolved. Do not use hot water to reconstitute unless the label specifically allows it, and always allow the solution to cool to a comfortable temperature before giving it to a child. Prepare a fresh solution for each day of use and discard any portion not consumed within 24 hours.

Oral rehydration therapy (ORT) agent; electrolyte and carbohydrate (glucose) replacement solution.

Oral Rehydration Salt [Flavored] acts via the sodium-glucose co-transport (SGLT1) mechanism in the small intestine: glucose facilitates active co-transport of sodium across the intestinal brush border, and water is passively drawn along the resulting osmotic gradient, replacing fluid and electrolytes lost through diarrhoea or vomiting. Potassium and citrate in the formulation correct associated electrolyte deficits and the metabolic acidosis often seen with dehydration.

ACI ORS Fruity is widely used in infants and children for the prevention and treatment of dehydration due to acute diarrhoea, per WHO/UNICEF recommendations, using age-based volumes as outlined in Dosage and Administration. It should always be prepared with the exact stated volume of clean water. Breastfeeding and age-appropriate normal feeding should continue during use. Safety and efficacy of specific flavoured formulations may vary by product and age group; parents/caregivers should follow the product label and seek paediatric medical advice for infants under 6 months, malnourished children, or if signs of severe dehydration, bloody diarrhoea, high fever, or persistent vomiting develop.